Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1228 of 5804
-
New hepatitis b drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis is a Phase 2 study to evaluate efficacy and safety of 48 weeks of oral once daily monotherapy with ALG-000184 versus tenofovir disproxil fumarate (TDF) for chronic HBV infection.
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental combo aims to outsmart resistant blood cancer
Disease control Recruiting nowThe goal of this interventional clinical trial is to evaluate the safety and tolerability of leflunomide in combination with decitabine as treatment for patients with relapsed or refractory myelodysplastic syndromes (R/R MDS). The main question this study aims to answer are to e…
Phase: PHASE1, PHASE2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New antibody aims to calm eczema Flare-Ups from the inside
Disease control Recruiting nowThis is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Phase: PHASE2 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Real-World study tests nemolizumab for persistent eczema itch
Disease control Recruiting nowThe main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.
Sponsor: Galderma R&D • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo radiation therapy aims to tame large brain tumors
Disease control Recruiting nowWhen cancer spreads to the brain, doctors often use a precise type of radiation therapy called stereotactic radiosurgery (SRS) to treat these tumors. This treatment can effectively control brain tumors while helping protect healthy brain tissue. However, when brain tumors or the …
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 26, 2026 15:18 UTC
-
Microwave zapper could replace lung surgery for some cancers
Disease control Recruiting nowThis study involves the use of a medical device, the Creo Medical MicroBlate Flex instrument, to heat and destroy lung tumour cells using microwave energy (this is also called ablation). In this study, the investigators are investigating whether the ablation instrument can be use…
Sponsor: Creo Medical Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New app aims to ease grief and prevent suicide after losing a baby
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the Along With Me web-based intervention works to decrease posttraumatic stress symptoms and suicidal ideation among bereaved parents following pregnancy and early infant loss. It will also learn whether peer guides provide additiona…
Phase: NA • Sponsor: Oregon Research Behavioral Intervention Strategies, Inc. • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New antibody drug targets deadly heart shock in early trial
Disease control Recruiting nowThe objective of this Phase 1b/2a trial is to evaluate the safety, tolerability, and exploratory efficacy of invobenitug (also known as procizumab), a monoclonal antibody under development for the treatment of cardiogenic shock (CS). CS is a life-threatening hypoperfusion of vita…
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Can a nightly eye drop stop kids' eyesight from getting worse?
Disease control Recruiting nowIn this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction
Phase: PHASE2 • Sponsor: Liaquat National Hospital & Medical College • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for Hard-to-Treat cancers: experimental drug enters human trials
Disease control Recruiting nowThis is a Phase 1 and Phase 2 study of GV20-0251 being developed for the treatment of participants with advanced solid tumors, who are refractory to approved therapies or other standard of care.
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Tonsil surgery may straighten spines in kids with sleep apnea
Disease control Recruiting nowThis study aims to determine the effect of adenotonsillectomy (AT) surgery on the progression of spinal curvature in children with mild sleep-disordered breathing (SDB) and concurrent scoliosis, as well as its potential role in preventing the de novo development of scoliosis in c…
Phase: NA • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New eczema ointment shows promise in early trial
Symptom relief Recruiting nowThis is a Phase 2, randomized, double-blind, vehicle-controlled clinical study evaluating the efficacy and safety of GX-03 topical ointment in adult subjects with moderate to severe atopic dermatitis (eczema). The study plans to enroll up to 120 eligible patients with a target of…
Phase: PHASE2 • Sponsor: Turn Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Placental grafts show promise for stubborn diabetic foot sores
Disease control Recruiting nowThe goal of this study is to determine the between-arm difference in the proportion of subjects achieving complete closure of nonhealing diabetic foot ulcers with multiple CAMPs plus SOC versus matched controls over 12 weeks using a modified platform trial design.
Phase: PHASE4 • Sponsor: Sequence LifeScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New pill shows promise for stubborn hives in Head-to-Head trial
Symptom relief Recruiting nowThis is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth \[p.o.\]) compared to dupilumab (600 mg loading dose administered subcutaneously (s.c.) followed by 300 mg every 2 weeks …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
AI-Powered app could help diabetics predict blood sugar and dose insulin smarter
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of integrating predictive models into insulin therapy management via the user-centered glUCModel mobile app in People with Type 1 Diabetes Mellitus following Multiple Insulin Dosing therapy. Participants will …
Phase: NA • Sponsor: Universidad Complutense de Madrid • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could diabetes drugs be the key to halting heart disease?
Disease control Recruiting nowThe purpose of the study is to compare the anti-atherosclerotic efficacy of oral treatment with a GLP-1 analogue (semaglutide) or an SGLT-2 (so-called "flozin") inhibitor (dapagliflozin) versus routine treatment (metformin) in patients with pre-diabetes and diagnosed coronary art…
Phase: PHASE4 • Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug cocktail aims to fight Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase I/II study to preliminarily explore of the safety, tolerability, pharmacokinetics, and efficacy of WJB001 combination therapy, consisting of three stages: Dose escalation (Phase Ia), dose extension (Phase Ib), and efficacy extension (Phase II). The preliminary pla…
Phase: PHASE1, PHASE2 • Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Exercise and diet combo shows promise for stiff arteries in hypertension
Disease control CompletedCardiovascular disease (CVD) is one of the leading causes of mortality worldwide and a major risk factor for morbidity worldwide . It is necessary to reduce the incidence and risk factors of CVD, as physical activity is known to reduce mortality from CVD. Arterial stiffness and h…
Phase: NA • Sponsor: Deraya University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for advanced cancer patients with HER-2 tumors
Disease control OngoingTo Observe and Evaluate the Safety Profile of Trastuzumab Rezetecan Alone or in Combination in Patients with HER-2 Protein-Expressing Recurrent or Metastatic Malignant Solid Tumors in a Real-World Setting.
Sponsor: Lixiaoling • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a Pre-Surgery immune booster tame brain cancer?
Disease control Recruiting nowWinGlio is a phase I study investigating neoadjuvant (before surgery) ipilimumab ( a type of immunotherapy drug) in patients with newly diagnosed glioblastoma (a form of brain cancer). Participants will receive up to 2 cycles of ipilimumab prior to the standard of care treatments…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC